Annual Working Capital
$384.25 M
-$2.78 M-0.72%
December 31, 2024
Summary
- As of March 10, 2025, BHVN annual working capital is $384.25 million, with the most recent change of -$2.78 million (-0.72%) on December 31, 2024.
- During the last 3 years, BHVN annual working capital has risen by +$42.19 million (+12.34%).
- BHVN annual working capital is now -22.68% below its all-time high of $496.95 million, reached on December 31, 2022.
Performance
BHVN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$384.25 M
+$96.04 M+33.32%
December 31, 2024
Summary
- As of March 10, 2025, BHVN quarterly working capital is $384.25 million, with the most recent change of +$96.04 million (+33.32%) on December 31, 2024.
- Over the past year, BHVN quarterly working capital has stayed the same.
- BHVN quarterly working capital is now -35.42% below its all-time high of $594.97 million, reached on March 1, 2022.
Performance
BHVN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BHVN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | 0.0% |
| 3 y3 years | +12.3% | -22.7% |
| 5 y5 years | +46.6% | -22.7% |
BHVN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.7% | +12.3% | -35.4% | +637.3% |
| 5 y | 5-year | -22.7% | +46.6% | -35.4% | +637.3% |
| alltime | all time | -22.7% | >+9999.0% | -35.4% | +2287.7% |
Biohaven Pharmaceutical Holding Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $384.25 M(-0.7%) | $384.25 M(+33.3%) |
| Sep 2024 | - | $288.21 M(-18.8%) |
| Jun 2024 | - | $355.06 M(+35.4%) |
| Mar 2024 | - | $262.16 M(-32.3%) |
| Dec 2023 | $387.02 M(-22.1%) | $387.02 M(+55.8%) |
| Sep 2023 | - | $248.39 M(-28.3%) |
| Jun 2023 | - | $346.27 M(-19.6%) |
| Mar 2023 | - | $430.47 M(-13.4%) |
| Dec 2022 | $496.95 M(+45.3%) | $496.95 M(+853.6%) |
| Sep 2022 | - | $52.12 M(-89.6%) |
| Jun 2022 | - | $502.38 M(-15.6%) |
| Mar 2022 | - | $594.97 M(+73.9%) |
| Dec 2021 | $342.05 M(+5.0%) | - |
| Dec 2021 | - | $342.05 M(-29.1%) |
| Sep 2021 | - | $482.11 M(+80.3%) |
| Jun 2021 | - | $267.45 M(-47.0%) |
| Mar 2021 | - | $504.90 M(+55.0%) |
| Dec 2020 | $325.80 M | - |
| Dec 2020 | - | $325.80 M(-33.7%) |
| Sep 2020 | - | $491.17 M(+150.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $196.15 M(-44.3%) |
| Mar 2020 | - | $352.35 M(+34.4%) |
| Dec 2019 | $262.11 M(+3.7%) | - |
| Dec 2019 | - | $262.11 M(-30.3%) |
| Sep 2019 | - | $375.96 M(-12.5%) |
| Jun 2019 | - | $429.68 M(+111.0%) |
| Mar 2019 | - | $203.68 M(-19.4%) |
| Dec 2018 | $252.81 M(+98.7%) | - |
| Dec 2018 | - | $252.81 M(+50.7%) |
| Sep 2018 | - | $167.72 M(-21.9%) |
| Jun 2018 | - | $214.85 M(+119.7%) |
| Mar 2018 | - | $97.81 M(-23.1%) |
| Dec 2017 | $127.24 M(+690.6%) | - |
| Dec 2017 | - | $127.24 M(-19.2%) |
| Sep 2017 | - | $157.39 M(-17.6%) |
| Jun 2017 | - | $191.09 M(+406.5%) |
| Mar 2017 | - | $37.73 M(+134.4%) |
| Dec 2016 | $16.09 M(+932.9%) | - |
| Dec 2016 | - | $16.09 M |
| Dec 2015 | $1.56 M | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual working capital?
- What is the all time high annual working capital for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual working capital year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly working capital?
- What is the all time high quarterly working capital for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly working capital year-on-year change?
What is Biohaven Pharmaceutical Holding annual working capital?
The current annual working capital of BHVN is $384.25 M
What is the all time high annual working capital for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual working capital is $496.95 M
What is Biohaven Pharmaceutical Holding annual working capital year-on-year change?
Over the past year, BHVN annual working capital has changed by -$2.78 M (-0.72%)
What is Biohaven Pharmaceutical Holding quarterly working capital?
The current quarterly working capital of BHVN is $384.25 M
What is the all time high quarterly working capital for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly working capital is $594.97 M
What is Biohaven Pharmaceutical Holding quarterly working capital year-on-year change?
Over the past year, BHVN quarterly working capital has changed by $0.00 (0.00%)